These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23317165)

  • 1. Recent developments of p38α MAP kinase inhibitors as antiinflammatory agents based on the imidazole scaffolds.
    Kong TT; Zhang CM; Liu ZP
    Curr Med Chem; 2013; 20(15):1997-2016. PubMed ID: 23317165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological testing of N-aminoimidazole-based p38alpha MAP kinase inhibitors.
    Bracht C; Hauser DR; Schattel V; Albrecht W; Laufer SA
    ChemMedChem; 2010 Jul; 5(7):1134-42. PubMed ID: 20473979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of p38 mitogen-activated protein kinase inhibitors.
    Bolós J
    Mini Rev Med Chem; 2005 Sep; 5(9):857-68. PubMed ID: 16178727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases.
    Muth F; Günther M; Bauer SM; Döring E; Fischer S; Maier J; Drückes P; Köppler J; Trappe J; Rothbauer U; Koch P; Laufer SA
    J Med Chem; 2015 Jan; 58(1):443-56. PubMed ID: 25475894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore design of p38α MAP kinase inhibitors with either 2,4,5-trisubstituted or 1,2,4,5-tetrasubstituted imidazole scaffold.
    Scior T; Domeyer DM; Cuanalo-Contreras K; Laufer SA
    Curr Med Chem; 2011; 18(10):1526-39. PubMed ID: 21428890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein.
    Lee MR; Dominguez C
    Curr Med Chem; 2005; 12(25):2979-94. PubMed ID: 16378500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitor.
    Ali EMH; Abdel-Maksoud MS; Hassan RM; Mersal KI; Ammar UM; Se-In C; He-Soo H; Kim HK; Lee A; Lee KT; Oh CH
    Bioorg Med Chem; 2021 Feb; 31():115969. PubMed ID: 33422910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p38 MAP kinase inhibitors as anti inflammatory agents.
    Amir M; Somakala K; Ali S
    Mini Rev Med Chem; 2013 Dec; 13(14):2082-96. PubMed ID: 24107108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors.
    Dyckman AJ; Li T; Pitt S; Zhang R; Shen DR; McIntyre KW; Gillooly KM; Shuster DJ; Doweyko AM; Sack JS; Kish K; Kiefer SE; Newitt JA; Zhang H; Marathe PH; McKinnon M; Barrish JC; Dodd JH; Schieven GL; Leftheris K
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4633-7. PubMed ID: 21705217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38α mitogen-activated protein kinase inhibitors, a patent review (2005-2011).
    Fischer S; Koeberle SC; Laufer SA
    Expert Opin Ther Pat; 2011 Dec; 21(12):1843-66. PubMed ID: 22082194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tri- and tetrasubstituted imidazoles as p38α mitogen-activated protein kinase inhibitors.
    Laufer S; Hauser D; Stegmiller T; Bracht C; Ruff K; Schattel V; Albrecht W; Koch P
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6671-5. PubMed ID: 20934337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38alpha MAP kinase inhibitors with excellent in vivo antiinflammatory properties.
    Mader M; de Dios A; Shih C; Bonjouklian R; Li T; White W; López de Uralde B; Sánchez-Martinez C; del Prado M; Jaramillo C; de Diego E; Martín Cabrejas LM; Dominguez C; Montero C; Shepherd T; Dally R; Toth JE; Chatterjee A; Pleite S; Blanco-Urgoiti J; Perez L; Barberis M; Lorite MJ; Jambrina E; Nevill CR; Lee PA; Schultz RC; Wolos JA; Li LC; Campbell RM; Anderson BD
    Bioorg Med Chem Lett; 2008 Jan; 18(1):179-83. PubMed ID: 18039577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An optimized and versatile synthesis to pyridinylimidazole-type p38α mitogen activated protein kinase inhibitors.
    El-Gokha A; Laufer SA; Koch P
    Org Biomol Chem; 2015 Nov; 13(43):10699-704. PubMed ID: 26351018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression.
    Aston NM; Bamborough P; Buckton JB; Edwards CD; Holmes DS; Jones KL; Patel VK; Smee PA; Somers DO; Vitulli G; Walker AL
    J Med Chem; 2009 Oct; 52(20):6257-69. PubMed ID: 19772287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of naphthyl-N-acylhydrazone p38α MAPK inhibitors with in vivo anti-inflammatory and anti-TNF-α activity.
    Freitas RHCN; Cordeiro NM; Carvalho PR; Alves MA; Guedes IA; Valerio TS; Dardenne LE; Lima LM; Barreiro EJ; Fernandes PD; Fraga CAM
    Chem Biol Drug Des; 2018 Feb; 91(2):391-397. PubMed ID: 28815968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful structure-based design of recent p38 MAP kinase inhibitors.
    Karcher SC; Laufer SA
    Curr Top Med Chem; 2009; 9(7):655-76. PubMed ID: 19689372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Angle on MK2 Inhibition-Optimization and Evaluation of Prevention of Activation Inhibitors.
    Hedström U; Norberg M; Evertsson E; Lever SR; Munck Af Rosenschöld M; Lönn H; Bold P; Käck H; Berntsson P; Vinblad J; Liu J; Welinder A; Karlsson J; Snijder A; Pardali K; Andersson U; Davis AM; Mogemark M
    ChemMedChem; 2019 Oct; 14(19):1701-1709. PubMed ID: 31325352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase.
    Kim DK; Lim JH; Lee JA; Dewang PM
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4006-10. PubMed ID: 18571921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the structural determinants of imidazole scaffold-based derivatives as p38 MAP kinase inhibitors by computational explorations.
    Huang C; Li Y; Ren H; Wang J; Shao L; Zhang S; Li G; Yang L
    Curr Med Chem; 2012; 19(23):4024-37. PubMed ID: 22680637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzothiazole based inhibitors of p38alpha MAP kinase.
    Liu C; Lin J; Pitt S; Zhang RF; Sack JS; Kiefer SE; Kish K; Doweyko AM; Zhang H; Marathe PH; Trzaskos J; Mckinnon M; Dodd JH; Barrish JC; Schieven GL; Leftheris K
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1874-9. PubMed ID: 18296051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.